52
Views
0
CrossRef citations to date
0
Altmetric
Commentary

An investigation of cobalt toxicity on blood parameters and evaluation of deferasirox and desferrioxamine chelators in removing cobalt from biological system

, &
Pages 53-59 | Received 17 Aug 2013, Accepted 06 Oct 2013, Published online: 12 Nov 2013

References

  • Aisen P, Aasa R, Redfield AG. (1969). The chromium, manganese, and cobalt complexes of transferring. J Biol Chem 244:4628–33
  • Amiri A, Fatemi SJ, Fatemi SN. (2007). Removal of thallium by combining desferrioxamine and deferiprone chelators in rats. Biometals 20:159–63
  • Barceloux DG. (1999). Cobalt. Clin Toxicol 37:201–16
  • Dies DH. (1999). Microbial heavy metal resistance. Appl Microbial Biotechnol 51:730–50
  • Domingo JL, Llobet JM, Bernat R. (1984). A study of the effects of cobalt administered orally to rats. Archiv Farmacol Toxicol 10:13–20
  • Fatemi SJ, Amiri A, Bazargan MH, et al. (2007). Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat. Int J Artif Organs 30:902–5
  • Fatemi SJ, Kadir FH, Moore GR. (1991). Aluminum transport in blood serum. Binding of aluminum by human transferring in the presence of human albumin and citrate. Biochem J 280:527–32
  • Fatemi SJ, Sh Saljooghi A, Dahooee Balooch F, et al. (2011). Chelation of cadmium by combining deferasirox and deferiprone in rats. Toxicol Indus Health 27:371–7
  • Fatemi SJ, Tubafard S, Nadi B. (2009). Evaluation of the effect of cadmium on rat organs and investigation of diethyl carbamate as an oral drug in treatment of cadmium toxicity. Med Chem Res 18:179–86
  • Fisher JW, Langston JW. (1968). Effects of testosterone, cobalt and hypoxia on erythropoietin production in the isolated perfused dog kidney. Ann N Y Acad Sci 149:75–87
  • Haga Y, Cline N, Hatori N, et al. (1996). Impaired myocardial function following chronic cobalt exposure in an isolated rat heart model. Trace Elem Electrolytes 13:69–74
  • Harriss WR, Messori L. (2002). A comparative study of aluminum (III), gallium (III), indium (III) and thallium (III) binding to human serum transferring. Coord Chem Rev 228:237–62
  • Hershko C, Konijn AM, Nike HP, et al. (2001). ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 97:1115–22
  • Hille B. (1992). Ionic channels of excitable membranes. 2nd ed. Sunderland, MA: Sinauer
  • Lauwerys R, Lison D. (1994). Health risks associated with cobalt exposure-an overview. Sci Total Environ 150:1–6
  • Lippi G, Franchini M, Guidi GC. (2005). Cobalt chloride administration in athletes: a new perspective in blood doping? Br J Sports Med 39:872–3
  • Mathur N, Jain GC, Pandey G. (2011). Hepatotoxicity of cobalt chloride in albino rat. Parmacologyonline 2:179–85
  • Pagana KD, Pagana TJ. (2010). Mosby's manual of diagnostic and laboratory tests. 4th ed. Mosby Elsevier
  • Roesems GM, Hoet PH, Dinsdale D, et al. (2000). In vitro cytotoxicity of various form of cobalt for alveolar macrophages and type II pneumocyts. Toxicol Appl Pharmacol 162:2–9
  • Schade SG, Felsher BF, Bernier GM, Conrad ME. (1970). Interrelationship of cobalt and iron absorption. J Lab Clin Med 74:435–6
  • Shrivastava VK, David CV, Khare N, Khare N. (1996). Cobalt chloride induced histopathological changes in thyroid gland of female mice, Mus musculus (P). Pollut Res 15:307–9
  • Sh Saljooghi A, Fatemi SJ. (2011). Removal of thallium by deferasirox in rats as biological model. J Appl Toxicol 31:139–43
  • Simonsen LO, Brown AM, Harbak H, et al. (2011). Cobalt uptake and binding in human red blood cells. Blood Cells Mol Dis 46:266–76
  • Simonsen LO, Harbak H, Bennekou P. (2012). Cobalt metabolism and toxicology – a brief update. Sci Total Environ 432:210–15
  • Söremark R, Diab M, Arvidson K. (1979). Autoradiographic study of distribution patters of metals which occur as corrosion products from dental restorations. Scand J Dent Res 87:4508–9
  • Summers MR, Jacobes A, Tudway D, et al. (1979). Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol 42:547–55
  • Taher AD, Cappellini M, Vichinsky E, et al. (2009). Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anemia and iron overload. Br J Haematol 147:752–9
  • Tubafard S, Fatemi SJ. (2008). Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicol Indus Health 24:235–40
  • Tubafard S, Fatemi SJ, Shokooh Saljooghi A, Torkzadeh M. (2010). Removal of vanadium by combining Desferrioxamine and deferiprone chelators in rats. Med Chem Res 19:854–63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.